<b>Viriom</b> Obtains First Market Approval Of Elsulfavirine (Elpida) For Treatment Of HIV-1 Infection In Russia Post author:Sam Post published:July 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Massachusetts' Agenus Quietly Discloses Failure of Cancer Vaccine Trial February 21, 2017 Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017 Is There a Biotech Bubble Brewing in Boston? March 20, 2018
Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017